Curis
CRIS
#10233
Rank
NZ$25.82 M
Marketcap
NZ$2.00
Share price
-10.08%
Change (1 day)
-67.71%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): NZ-$6.38

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$6.32. In 2024 the company made an earnings per share (EPS) of NZ-$12.11 an increase over its 2023 EPS that were of NZ-$15.53.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.38-47.28%
2024NZ-$12.11-22.06%
2023NZ-$15.53-26.25%
2022NZ-$21.0622.3%
2021NZ-$17.22-25.37%
2020NZ-$23.07-30.93%
2019NZ-$33.41-2.02%
2018NZ-$34.10
2016NZ-$77.49-10%
2015NZ-$86.10138.1%
2014NZ-$36.1640%
2013NZ-$25.83-25%
2012NZ-$34.4466.67%
2011NZ-$20.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Exelixis
EXEL
NZ$4.10-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.43-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.62-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$5.82-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.96-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.11-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$19.36 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA